These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 8125142

  • 1. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.
    Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde KH, Boon T.
    Eur J Immunol; 1994 Mar; 24(3):759-64. PubMed ID: 8125142
    [Abstract] [Full Text] [Related]

  • 2. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
    Brichard VG, Herman J, Van Pel A, Wildmann C, Gaugler B, Wölfel T, Boon T, Lethé B.
    Eur J Immunol; 1996 Jan; 26(1):224-30. PubMed ID: 8566071
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
    Valmori D, Pittet MJ, Vonarbourg C, Rimoldi D, Liénard D, Speiser D, Dunbar R, Cerundolo V, Cerottini JC, Romero P.
    Cancer Res; 1999 Aug 15; 59(16):4050-5. PubMed ID: 10463606
    [Abstract] [Full Text] [Related]

  • 4. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
    van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A, Boon T.
    Eur J Immunol; 1994 Dec 15; 24(12):3038-43. PubMed ID: 7805731
    [Abstract] [Full Text] [Related]

  • 5. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y, Robbins PF, Wang X, Tupesis JP, Parkhurst MR, Kang X, Sakaguchi K, Appella E, Rosenberg SA.
    J Immunol; 1998 Dec 15; 161(12):6985-92. PubMed ID: 9862734
    [Abstract] [Full Text] [Related]

  • 6. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
    Viret C, Davodeau F, Guilloux Y, Bignon JD, Semana G, Breathnach R, Jotereau F.
    Eur J Immunol; 1993 Jan 15; 23(1):141-6. PubMed ID: 8419164
    [Abstract] [Full Text] [Related]

  • 7. Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase.
    Riley JP, Rosenberg SA, Parkhurst MR.
    J Immunother; 2001 Jan 15; 24(3):212-20. PubMed ID: 11394498
    [Abstract] [Full Text] [Related]

  • 8. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells.
    Visseren MJ, van Elsas A, van der Voort EI, Ressing ME, Kast WM, Schrier PI, Melief CJ.
    J Immunol; 1995 Apr 15; 154(8):3991-8. PubMed ID: 7706738
    [Abstract] [Full Text] [Related]

  • 9. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P.
    Cancer Res; 1997 Feb 15; 57(4):735-41. PubMed ID: 9044853
    [Abstract] [Full Text] [Related]

  • 10. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.
    Kittlesen DJ, Thompson LW, Gulden PH, Skipper JC, Colella TA, Shabanowitz J, Hunt DF, Engelhard VH, Slingluff CL.
    J Immunol; 1998 Mar 01; 160(5):2099-106. PubMed ID: 9498746
    [Abstract] [Full Text] [Related]

  • 11. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.
    van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, Melief CJ, Schrier PI.
    Eur J Immunol; 1996 Aug 01; 26(8):1683-9. PubMed ID: 8765006
    [Abstract] [Full Text] [Related]

  • 12. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC, Boon T.
    J Exp Med; 1994 Jul 01; 180(1):35-42. PubMed ID: 8006593
    [Abstract] [Full Text] [Related]

  • 13. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T, Irie RF, Nishinaka Y, Hoon DS.
    Clin Cancer Res; 1997 Aug 01; 3(8):1363-70. PubMed ID: 9815820
    [Abstract] [Full Text] [Related]

  • 14. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients.
    Takahashi T, Irie RF, Morton DL, Hoon DS.
    Cell Immunol; 1997 Jun 15; 178(2):162-71. PubMed ID: 9225007
    [Abstract] [Full Text] [Related]

  • 15. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
    Kubo H, Abe J, Obata F, Nakajima H, Tsunoda M, Ogawa A, Nakayama S, Beck Y, Kohsaka T, Darrow TL, Abdel-Wahab Z, Saida T, Takiguchi M.
    Cancer Res; 1996 May 15; 56(10):2368-74. PubMed ID: 8625313
    [Abstract] [Full Text] [Related]

  • 16. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.
    Kang X, Kawakami Y, el-Gamil M, Wang R, Sakaguchi K, Yannelli JR, Appella E, Rosenberg SA, Robbins PF.
    J Immunol; 1995 Aug 01; 155(3):1343-8. PubMed ID: 7543520
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
    Jenne L, Arrighi JF, Jonuleit H, Saurat JH, Hauser C.
    Cancer Res; 2000 Aug 15; 60(16):4446-52. PubMed ID: 10969791
    [Abstract] [Full Text] [Related]

  • 18. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E.
    J Immunol; 1995 Mar 01; 154(5):2257-65. PubMed ID: 7868898
    [Abstract] [Full Text] [Related]

  • 19. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T.
    J Exp Med; 1993 Aug 01; 178(2):489-95. PubMed ID: 8340755
    [Abstract] [Full Text] [Related]

  • 20. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ, Chan HW, Karbach J, Salter RD, Knuth A, Lotze MT, Storkus WJ.
    Eur J Immunol; 1996 Nov 01; 26(11):2613-23. PubMed ID: 8921947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.